Compound Detail
CHEMBL15245
YOHIMBINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
Basic Information
| ChEMBL ID | CHEMBL15245 |
| Name | YOHIMBINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
| Therapeutic | ✓ Yes |
40
Targets
212
Activities
4
Assay Types
5
PK Parameters
20
Publications
2
Known Names
10
Indications
Molecular Properties
354.4
MW (Da)
2.65
ALogP
4
HBA
2
HBD
65.6
PSA (Ų)
0.77
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Erectile Dysfunction Alcoholism Cocaine-Related Disorders Diabetes Mellitus, Type 2 Opioid-Related Disorders Stress Disorders, Post-Traumatic Hypotension, Orthostatic Marijuana Abuse Orthostatic Intolerance Parkinson Disease
ATC Classification
G04BE04
yohimbine
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
Ki 116 meas. best 10.4
IC50 51 meas. best 8.21
Kd 42 meas. best 8.32
EC50 3 meas. best 8.07
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 10.4 | 10.4 | 0.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 9.6 | 8.9778 | 0.3 | 9 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | Ki | 9.4 | 8.25 | 0.4 | 13 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 9.38 | 8.5464 | 0.4 | 11 |
| Alpha-2 adrenergic receptor CHEMBL2111338 | Ki | 9.22 | 8.3033 | 0.6 | 3 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 9.22 | 7.6884 | 0.6 | 19 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 8.96 | 7.4775 | 1.1 | 4 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 8.94 | 8.304 | 1.2 | 10 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 8.8 | 7.11 | 1.6 | 4 |
| Alpha-2B adrenergic receptor CHEMBL266 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL4892 | Ki | 8.44 | 7.115 | 3.6 | 4 |
| Alpha-2A adrenergic receptor CHEMBL2350 | Ki | 8.36 | 8.36 | 4.4 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Kd | 8.32 | 8.205 | 4.8 | 2 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 8.21 | 8.035 | 6.2 | 4 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 8.14 | 6.5827 | 7.2 | 11 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 8.11 | 7.775 | 7.7 | 2 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | IC50 | 8.1 | 7.0514 | 8.0 | 7 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 8.08 | 6.885 | 8.4 | 2 |
| Alpha-2A adrenergic receptor CHEMBL1867 | EC50 | 8.07 | 7.945 | 8.5 | 2 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 8.04 | 7.2888 | 9.1 | 8 |
| Alpha-2 adrenergic receptor CHEMBL2111338 | Kd | 7.98 | 7.98 | 10.5 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Kd | 7.91 | 7.56 | 12.3 | 11 |
| Cavia porcellus CHEMBL369 | Kd | 7.9 | 7.9 | 12.6 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 7.77 | 7.415 | 17.0 | 2 |
| Rattus norvegicus CHEMBL376 | Kd | 7.65 | 7.085 | 22.4 | 2 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | Ki | 7.6 | 7.6 | 25.1 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | Kd | 7.59 | 6.2322 | 25.7 | 9 |
| Unchecked CHEMBL612545 | Ki | 7.48 | 7.285 | 33.0 | 4 |
| Unchecked CHEMBL612545 | IC50 | 7.42 | 7.0733 | 38.0 | 3 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 7.37 | 7.35 | 43.0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL3762 | Ki | 7.35 | 7.35 | 45.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL4744 | Ki | 7.31 | 7.31 | 49.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 7.3 | 7.3 | 50.1 | 1 |
| Alpha-1D adrenergic receptor CHEMBL326 | Ki | 7.28 | 7.28 | 52.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 7.14 | 7.14 | 72.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 7.13 | 7.13 | 74.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 6.9 | 6.9 | 126.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | Ki | 6.85 | 6.6771 | 140.0 | 7 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 6.83 | 6.465 | 147.9 | 2 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 6.7 | 6.34 | 199.5 | 2 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.44 | 6.41 | 360.0 | 4 |
| Alpha-1A adrenergic receptor CHEMBL229 | Kd | 6.4 | 6.4 | 398.1 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.4 | 6.28 | 398.1 | 2 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 6.3 | 6.3 | 500.0 | 1 |
| Rattus norvegicus CHEMBL376 | Ki | 6.3 | 6.3 | 505.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 6.18 | 6.18 | 658.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 6.11 | 6.11 | 784.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 6.0 | 5.8967 | 1000.0 | 3 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 5.99 | 5.99 | 1013.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 34.4 | mL.min-1.g-1 | Homo sapiens |
| CL | 7.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 2.0 | mL.min-1.g-1 | Rattus norvegicus |
| T1/2 | 0.06167 | hr | Mus musculus |
| T1/2 | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7658428 | 10.1021/jm00018a001 | Adrenergic receptor alpha-2 | 19 |
| 38857067 | 10.1021/acs.jmedchem.4c00323 | ADMET | 13 |
| - | 10.1016/0960-894X(96)00406-4 | Adrenergic receptor alpha-2 | 12 |
| 16407989 | 10.1038/nchembio705 | Alpha-2A adrenergic receptor | 12 |
| 38857067 | 10.1021/acs.jmedchem.4c00323 | Alpha-2A adrenergic receptor | 8 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 7 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 7 |
| 8487254 | 10.1021/jm00061a004 | Cytochrome P450 2D6 | 6 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 5 |
| 11602674 | - | ATP-dependent translocase ABCB1 | 5 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 4 |
| 17181165 | 10.1021/jm060743g | Mus musculus | 4 |
| 2887657 | 10.1021/jm00392a005 | Adrenergic receptor alpha-2 | 4 |
| 2570150 | 10.1021/jm00129a002 | Unchecked | 3 |
| 23403082 | 10.1016/j.bmcl.2013.01.025 | Alpha-2A adrenergic receptor | 3 |
| 1671705 | 10.1021/jm00106a036 | Adrenergic receptor alpha-2 | 3 |
| 2886664 | 10.1021/jm00391a015 | Adrenergic receptor alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 3 |
Data from ChEMBL 36 via Core Engine